Your browser doesn't support javascript.
loading
[Bone marrow involvement in primary mediastinal B-cell lymphoma]. / Porazhenie kostnogo mozga pri pervichnoi mediastinal'noi V-krupnokletochnoi limfome.
Magomedova, A U; Fastova, E A; Kovrigina, A M; Obukhova, T N; Skidan, N I; Mangasarova, Ya K; Vorobyev, A I; Kravchenko, S K.
Afiliación
  • Magomedova AU; National Research Center for Hematology, Ministry of Health of Russia, Moscow, Russia.
  • Fastova EA; National Research Center for Hematology, Ministry of Health of Russia, Moscow, Russia.
  • Kovrigina AM; National Research Center for Hematology, Ministry of Health of Russia, Moscow, Russia.
  • Obukhova TN; National Research Center for Hematology, Ministry of Health of Russia, Moscow, Russia.
  • Skidan NI; National Research Center for Hematology, Ministry of Health of Russia, Moscow, Russia.
  • Mangasarova YK; National Research Center for Hematology, Ministry of Health of Russia, Moscow, Russia.
  • Vorobyev AI; National Research Center for Hematology, Ministry of Health of Russia, Moscow, Russia.
  • Kravchenko SK; National Research Center for Hematology, Ministry of Health of Russia, Moscow, Russia.
Ter Arkh ; 89(7): 65-68, 2017.
Article en Ru | MEDLINE | ID: mdl-28766543
Primary mediastinal large B-cell lymphoma (PMBCL) is a distinct type of large B-cell lymphoma. In this type of the disease, the neoplastic process is located in the anterior and superior mediastinum, frequently with compression of the superior vena cava and with tumor invasion into the adjacent organs and tissues: the pericardium, lung, pleura, etc. Despite the fact that in PMBCL progression, there may be involvement of extranodal organs, such as the kidney, adrenal glands, liver, and central nervous system, bone marrow (BM) injury is generally absent. Since BM injury in patients with diffuse large B-cell lymphoma is an independent poor prognostic indicator, there is reason to believe that BM involvement in PMBCL affects the prognosis. These cases may need intensified induction therapy followed by autologous hematopoietic stem cell transplantation; and BM injury should be monitored during the therapy. The paper gives reports of clinical cases of bone marrow involvement in 2 PMBCL patients treated at the National Research Center for Hematology, Ministry of Health of the Russian Federation.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Médula Ósea / Síndrome de la Vena Cava Superior / Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma de Células B / Trasplante de Células Madre Hematopoyéticas / Ganglios Linfáticos / Neoplasias del Mediastino Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies Límite: Adult / Female / Humans / Middle aged Idioma: Ru Revista: Ter Arkh Año: 2017 Tipo del documento: Article País de afiliación: Rusia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Médula Ósea / Síndrome de la Vena Cava Superior / Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma de Células B / Trasplante de Células Madre Hematopoyéticas / Ganglios Linfáticos / Neoplasias del Mediastino Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies Límite: Adult / Female / Humans / Middle aged Idioma: Ru Revista: Ter Arkh Año: 2017 Tipo del documento: Article País de afiliación: Rusia